MX2018002507A - Metodo para la inhibicion de la absorcion de lipidos y/o la promocion de excrecion de lipidos usando d-psicosa. - Google Patents

Metodo para la inhibicion de la absorcion de lipidos y/o la promocion de excrecion de lipidos usando d-psicosa.

Info

Publication number
MX2018002507A
MX2018002507A MX2018002507A MX2018002507A MX2018002507A MX 2018002507 A MX2018002507 A MX 2018002507A MX 2018002507 A MX2018002507 A MX 2018002507A MX 2018002507 A MX2018002507 A MX 2018002507A MX 2018002507 A MX2018002507 A MX 2018002507A
Authority
MX
Mexico
Prior art keywords
lipid
psicose
present
lipids
functional food
Prior art date
Application number
MX2018002507A
Other languages
English (en)
Inventor
HAN Youngji
Kwon Eun-Young
Choi Myung-Sook
Original Assignee
Cj Cheiljedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Cheiljedang Corp filed Critical Cj Cheiljedang Corp
Publication of MX2018002507A publication Critical patent/MX2018002507A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)

Abstract

La presente invención se relaciona con una composición para la prevención o tratamiento de enfermedades metabólicas relacionadas con lípidos. La composición de acuerdo con la presente invención comprende D-psicosa como ingrediente activo. La D-psicosa tiene la capacidad de inhibir la absorción de lípidos en el intestino delgado y aumentar considerablemente los niveles de lípidos en las heces. Debido a su capacidad, la D-psicosa es efectiva para inhibir la formación de grasa corporal. Además, la D-psicosa reduce el peso corporal, la masa de grasa corporal y los lípidos plasmáticos a niveles normales para normalizar el peso corporal, la masa de grasa corporal y los perfiles de lípidos en plasma. Debido a estas ventajas, se espera que la D-psicosa encuentre aplicación en medicamentos farmacéuticos, alimentos funcionales para la salud y alimentos funcionales adecuados para la prevención y/o tratamiento de enfermedades metabólicas relacionadas con los lípidos.
MX2018002507A 2015-09-01 2016-09-01 Metodo para la inhibicion de la absorcion de lipidos y/o la promocion de excrecion de lipidos usando d-psicosa. MX2018002507A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150123437A KR101692033B1 (ko) 2015-09-01 2015-09-01 D-싸이코스를 유효성분으로 함유하는 지질 관련 대사성 질환의 예방 또는 치료용 조성물
PCT/KR2016/009812 WO2017039365A1 (ko) 2015-09-01 2016-09-01 D-싸이코스를 이용한 지질 흡수 억제 및/또는 배출 촉진 방법

Publications (1)

Publication Number Publication Date
MX2018002507A true MX2018002507A (es) 2018-06-11

Family

ID=57797262

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018002507A MX2018002507A (es) 2015-09-01 2016-09-01 Metodo para la inhibicion de la absorcion de lipidos y/o la promocion de excrecion de lipidos usando d-psicosa.

Country Status (13)

Country Link
US (1) US20180243325A1 (es)
EP (1) EP3345608A4 (es)
JP (1) JP6619882B2 (es)
KR (1) KR101692033B1 (es)
CN (1) CN107921052A (es)
BR (1) BR112018003842A2 (es)
CA (1) CA2996872A1 (es)
CL (1) CL2018000523A1 (es)
CO (1) CO2018002394A2 (es)
MX (1) MX2018002507A (es)
RU (1) RU2725145C2 (es)
UA (1) UA122342C2 (es)
WO (1) WO2017039365A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019006956B1 (pt) * 2016-10-06 2023-05-09 Cj Cheiljedang Corporation Ketchup e um método para melhorar a conservação deste
KR101981397B1 (ko) 2016-10-07 2019-05-23 씨제이제일제당 (주) 알룰로스 및 염을 포함하는 미질이 개선된 감미료 조성물 및 염을 이용한 알룰로스의 미질 개선 방법
CN110022690A (zh) 2016-12-21 2019-07-16 Cj第一制糖株式会社 含有阿洛酮糖的氨基酸饮料
MX2019005996A (es) 2016-12-26 2019-08-21 Cj Cheiljedang Corp Composicion que contiene alulosa para promover la excrecion de lipidos vegetales del cuerpo.
CN111511372A (zh) * 2017-10-27 2020-08-07 株式会社三养社 预防或减轻非酒精性脂肪肝疾病的组合物
JP7216260B2 (ja) * 2018-11-06 2023-02-01 株式会社明治 コプロコッカス属菌の増殖促進用組成物
MX2021005451A (es) * 2018-11-08 2021-06-18 Univ Kagawa Nat Univ Corp Agente activador de adipocitos pardos y beige que contiene d-alulosa como ingrediente activo.
JP7158021B2 (ja) * 2018-11-29 2022-10-21 松谷化学工業株式会社 Cdca増加促進用組成物、fxr増加促進用組成物及びfxr活性化促進用組成物
CN113453755A (zh) * 2019-02-19 2021-09-28 国立大学法人香川大学 以植物体的形态利用包含生物体内功能成分的日本鼠刺的口服组合物
JP2020132588A (ja) * 2019-02-21 2020-08-31 松谷化学工業株式会社 血中pcsk9濃度上昇抑制用組成物
EP3698648A1 (en) * 2019-02-22 2020-08-26 Pfeifer & Langen GmbH & Co. KG Allulose pet food

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1757297B1 (en) * 2004-05-26 2013-11-13 National University Corporation Kagawa University COMPOSITION FOR treating ARTERIOSCLEROSIS IN DIABETIC PATIENTS
JP5535456B2 (ja) * 2008-07-09 2014-07-02 松谷化学工業株式会社 食物繊維と希少糖を含む生体機能改善組成物。

Also Published As

Publication number Publication date
CO2018002394A2 (es) 2018-07-19
CA2996872A1 (en) 2017-03-09
US20180243325A1 (en) 2018-08-30
KR101692033B1 (ko) 2017-01-03
BR112018003842A2 (pt) 2018-09-25
EP3345608A4 (en) 2019-05-01
RU2018111327A (ru) 2019-10-04
CN107921052A (zh) 2018-04-17
JP2018530600A (ja) 2018-10-18
CL2018000523A1 (es) 2019-02-22
EP3345608A1 (en) 2018-07-11
JP6619882B2 (ja) 2019-12-11
WO2017039365A1 (ko) 2017-03-09
RU2725145C2 (ru) 2020-06-30
RU2018111327A3 (es) 2019-10-04
UA122342C2 (uk) 2020-10-26

Similar Documents

Publication Publication Date Title
MX2018002507A (es) Metodo para la inhibicion de la absorcion de lipidos y/o la promocion de excrecion de lipidos usando d-psicosa.
MY197024A (en) Amylin analogues
WO2016190683A8 (ko) 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
AR093217A1 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos
PH12017501674A1 (en) Amylin analogues
MX359626B (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o afecciones asociadas con disfunción mitocondrial.
WO2018093238A3 (ko) 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
MX346494B (es) Compuestos novedosos como inhibidores de diacilglicerol aciltransferasa.
EA033540B1 (ru) Композиция, включающая окру, для применения в уменьшении абсорбции пищевого жира
PH12015502263A1 (en) Composition for preventing or treating hangover
WO2016190682A3 (ko) 모루신, 구와논 지 또는 상백피를 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
MX2016009306A (es) Reequilibrado inmunologico epicutaneo.
WO2015109299A3 (en) Bamboo extracts, compositions and uses thereof
EA201592003A1 (ru) Микропищевые добавки для иммунитета
SG10201909382UA (en) Glyt1 inhibitors for use in the treatment of hematological disorders
MX2017006639A (es) Metodos y composiciones para preservar la masa corporal magra y promover la perdida de grasa durante la perdida de peso.
MX2015010296A (es) Tratamiento de formas progresivas de esclerosis multiple con laquinimod.
MX2016004909A (es) Composicion que contiene eugenol como principio activo para prevenir o tratar la dermatitis atopica.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
WO2018093237A3 (ko) 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
WO2011118957A3 (ko) 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물
EP3643302C0 (en) COMPOSITION WITH SESQUITERPENDERIVATE AS AN ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF MUSCLE DISEASES
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
PH12017500743A1 (en) Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
BR112016017765A8 (pt) composição compreendendo cinamaldeído e zinco, seu uso, e método para produzir um produto alimentício para perda de peso